<?xml version="1.0" encoding="UTF-8"?>
<drug type="biotech" created="2018-01-17" updated="2020-01-02">
  <drugbank-id primary="true">DB13965</drugbank-id>
  <name>Sarracenia Purpurea</name>
  <description>_Sarracenia purpurea_, commonly known as the purple pitcher plant, northern pitcher plant, turtle socks, or side-saddle flower, is a perennial carnivorous plant in the family _Sarraceniaceae_. _Sarracenia purpurea_ attract and trap insects within their pitchers, or fused leaves, to consume nitrogen during the digestion process [A32509]. It is widely distributed across North America and has been used as a traditional medicinal herb in many aboriginal communities [A32509, A32510]. It was used as an injectable pain reliever and during the 19th century, _Sarracenia purpurea_ was used as a treatment of smallpox [A32509]. Compounds extracted from _Sarracenia purpurea_ include phenolic glycosides, flavonoid glycosides, and iridoids. _In vitro_, there is evidence of glycosides potentiating glucose uptake with potential antidiabetic properties [A32510]. Cytoprotection in an in vitro model of diabetic neuropathy has also been studied. However, the use of Sarracenia Purpurea extracts in the clinical setting are limited.</description>
  <cas-number/>
  <unii>FOP08H143P</unii>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>experimental</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A32509</ref-id>
        <pubmed-id>23216659</pubmed-id>
        <citation>Harris CS, Asim M, Saleem A, Haddad PS, Arnason JT, Bennett SA: Characterizing the cytoprotective activity of Sarracenia purpurea L., a medicinal plant that inhibits glucotoxicity in PC12 cells. BMC Complement Altern Med. 2012 Dec 5;12:245. doi: 10.1186/1472-6882-12-245.</citation>
      </article>
      <article>
        <ref-id>A32510</ref-id>
        <pubmed-id>22738356</pubmed-id>
        <citation>Muhammad A, Guerrero-Analco JA, Martineau LC, Musallam L, Madiraju P, Nachar A, Saleem A, Haddad PS, Arnason JT: Antidiabetic compounds from Sarracenia purpurea used traditionally by the Eeyou Istchee Cree First Nation. J Nat Prod. 2012 Jul 27;75(7):1284-8. doi: 10.1021/np3001317. Epub 2012 Jun 27.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>No approved therapeutic indications. </indication>
  <pharmacodynamics>Extracts of _Sarracenia purpurea_ may enhance glucose uptake by attenuating glucose-6-phosphatase enzymatic activity and decreasing hepatic glucose production [A32510]. In an in vitro model of glucotoxicity in PC12 cells, treatment of _Sarracenia purpurea_ demonstrated cytoprotective effects and prevented glucose-mediated cell loss [A32509].</pharmacodynamics>
  <mechanism-of-action>The full mechanism of action of the antidiabetic and cytoprotective activity is not fully elucidated. </mechanism-of-action>
  <toxicity>No toxicokinetic data available. </toxicity>
  <metabolism>No pharmacokinetic data available. </metabolism>
  <absorption>No pharmacokinetic data available. </absorption>
  <half-life>No pharmacokinetic data available. </half-life>
  <protein-binding>No pharmacokinetic data available. </protein-binding>
  <route-of-elimination>No pharmacokinetic data available. </route-of-elimination>
  <volume-of-distribution>No pharmacokinetic data available. </volume-of-distribution>
  <clearance>No pharmacokinetic data available. </clearance>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">Frog's-britches whole</synonym>
    <synonym language="english" coder="">Huntsman's-horns whole</synonym>
    <synonym language="english" coder="">Pitcher plant</synonym>
    <synonym language="english" coder="">Pitcherplant whole</synonym>
    <synonym language="english" coder="">Purple pitcherplant whole</synonym>
    <synonym language="english" coder="">Sarracenia purpura</synonym>
    <synonym language="english" coder="">Sarracenia purpurea l.</synonym>
    <synonym language="english" coder="">Sarracenia purpurea whole</synonym>
    <synonym language="english" coder="">Sarracenia rosea whole</synonym>
    <synonym language="english" coder="">Sidesaddle-flower whole</synonym>
  </synonyms>
  <products>
    <product>
      <name>P-Bloc</name>
      <labeller>Creative Science, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>53413-752</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-11-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>12.5 mg/1mL</strength>
      <route>Parenteral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sarapin</name>
      <labeller>High Chemical Company</labeller>
      <ndc-id/>
      <ndc-product-code>10541-0012</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1935-01-31</started-marketing-on>
      <ended-marketing-on>2016-06-10</ended-marketing-on>
      <dosage-form>Injection</dosage-form>
      <strength>0.17 g/1mL</strength>
      <route>Intramuscular</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sarapin</name>
      <labeller>High Chemical Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00226882</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1942-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>100 %</strength>
      <route>Intramuscular</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>P-Bloc</name>
      <ingredients>Sarracenia Purpurea</ingredients>
    </mixture>
    <mixture>
      <name>Sarapin</name>
      <ingredients>Sarracenia Purpurea</ingredients>
    </mixture>
    <mixture>
      <name>Sarapin</name>
      <ingredients>Sarracenia Purpurea</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Miscellaneous Analgesics and Antipyretics</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Injection</form>
      <route>Parenteral</route>
      <strength>12.5 mg/1mL</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intramuscular</route>
      <strength>0.17 g/1mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intramuscular</route>
      <strength>100 %</strength>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes>
    <ahfs-code>28:08.92</ahfs-code>
  </ahfs-codes>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <sequences/>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>2662</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>